The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
The insulin-like growth factor 2 (<i>IGF2</i>) mRNA binding protein IMP2 (IGF2BP2) is an oncogenic protein known to be overexpressed in different tumor types. Pancreatic cancer is a very lethal cancer that requires early diagnosis and new treatment options. The aim of our study was to in...
Main Authors: | Charlotte Dahlem, Ahmad Barghash, Philip Puchas, Johannes Haybaeck, Sonja M. Kessler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/13/3204 |
Similar Items
-
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
by: Jason M. Biegel, et al.
Published: (2021-03-01) -
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
by: Scudamore Charles H, et al.
Published: (2010-02-01) -
IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
by: Xin He, et al.
Published: (2018-12-01) -
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis[S]
by: Stephan Laggai, et al.
Published: (2014-06-01) -
Imp/IGF2BP levels modulate individual neural stem cell growth and division through myc mRNA stability
by: Tamsin J Samuels, et al.
Published: (2020-01-01)